Other
Cognitive Functioning
Cognitive Functioning is an intervention with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(3)
Detailed Status
Completed3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A1 (100.0%)
Trials by Status
completed3100%
Recent Activity
0 active trials
Showing 3 of 3
completednot_applicable
Modulating Mechanisms in Patients With Chronic Subjective Tinnitus and/or Chronic Pain
NCT05186259
completed
Long Term Implications of Rare Brain Tumours'
NCT04708548
completed
Touch Screen Usage Time In Relation To Visual Motor Integration and Quality of Life In Preschoolers
NCT04524923
Clinical Trials (3)
Showing 3 of 3 trials
NCT05186259Not Applicable
Modulating Mechanisms in Patients With Chronic Subjective Tinnitus and/or Chronic Pain
NCT04708548
Long Term Implications of Rare Brain Tumours'
NCT04524923
Touch Screen Usage Time In Relation To Visual Motor Integration and Quality of Life In Preschoolers
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3